Abstract
Background: Sexual dysfunction is a common but frequently underrecognized consequence of gynecological cancer and its treatment. It may persist throughout survivorship and involve vaginal and hormonal changes, dyspareunia, pelvic floor dysfunction, psychological distress, altered body image, and relationship difficulties. Despite its substantial impact on quality of life, sexual health is not consistently addressed during routine follow-up. Objective: To evaluate contemporary treatment strategies for sexual dysfunction in gynecological cancer survivors and propose a personalized, multidisciplinary framework for sexual rehabilitation. Methods: A narrative literature search was conducted in PubMed/MEDLINE, Scopus, and Google Scholar, focusing primarily on publications from 1 January 2016 to 1 September 2026. The review considered randomized controlled trials, observational and qualitative studies, systematic reviews, meta-analyses, clinical practice guidelines, consensus statements, and relevant narrative reviews. Earlier landmark publications were retained when they provided essential clinical or historical evidence. A total of 63 publications were included in the narrative synthesis. Results: The evidence supports a multidimensional approach to sexual rehabilitation, beginning with structured assessment of sexual symptoms, oncological history, treatment-related effects, vaginal and hormonal status, pelvic floor function, psychological well-being, relationship context, and patient-defined goals. Treatment options include vaginal moisturizers and lubricants, selected local hormonal therapies, vaginal rehabilitation, pelvic floor physiotherapy, and psychological and psychosexual interventions. Treatment selection and sequencing should be guided by the predominant mechanisms of dysfunction, oncological context, and individual preferences. Evidence varies across interventions, and the effectiveness and safety of some modalities remain uncertain. Based on the reviewed evidence, a clinically oriented pathway is proposed to link assessment with mechanism-based treatment, multidisciplinary referral, and reassessment. Conclusions: Sexual dysfunction should not be considered an inevitable consequence of gynecological cancer survivorship. Individualized rehabilitation may provide a structured approach to addressing persistent sexual-health concerns. The proposed mechanism-oriented pathway represents a clinical synthesis intended to support assessment, treatment selection, multidisciplinary referral, and follow-up. Its effectiveness has not been established and requires prospective evaluation.